Table of Content

1 Nasolacrimal Stents Market Overview
1.1 Product Overview and Scope of Nasolacrimal Stents
1.2 Nasolacrimal Stents Segment by Type
1.2.1 Global Nasolacrimal Stents Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Monocanalicular Stents
1.2.3 Bicanalicular Stents
1.3 Nasolacrimal Stents Segment by Application
1.3.1 Nasolacrimal Stents Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Nasolacrimal Stents Market Size Estimates and Forecasts
1.4.1 Global Nasolacrimal Stents Revenue 2016-2027
1.4.2 Global Nasolacrimal Stents Sales 2016-2027
1.4.3 Nasolacrimal Stents Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nasolacrimal Stents Market Competition by Manufacturers
2.1 Global Nasolacrimal Stents Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nasolacrimal Stents Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nasolacrimal Stents Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nasolacrimal Stents Manufacturing Sites, Area Served, Product Type
2.5 Nasolacrimal Stents Market Competitive Situation and Trends
2.5.1 Nasolacrimal Stents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nasolacrimal Stents Players Market Share by Revenue
2.5.3 Global Nasolacrimal Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nasolacrimal Stents Retrospective Market Scenario by Region
3.1 Global Nasolacrimal Stents Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Nasolacrimal Stents Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Nasolacrimal Stents Market Facts & Figures by Country
3.3.1 North America Nasolacrimal Stents Sales by Country
3.3.2 North America Nasolacrimal Stents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nasolacrimal Stents Market Facts & Figures by Country
3.4.1 Europe Nasolacrimal Stents Sales by Country
3.4.2 Europe Nasolacrimal Stents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nasolacrimal Stents Market Facts & Figures by Region
3.5.1 Asia Pacific Nasolacrimal Stents Sales by Region
3.5.2 Asia Pacific Nasolacrimal Stents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nasolacrimal Stents Market Facts & Figures by Country
3.6.1 Latin America Nasolacrimal Stents Sales by Country
3.6.2 Latin America Nasolacrimal Stents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nasolacrimal Stents Market Facts & Figures by Country
3.7.1 Middle East and Africa Nasolacrimal Stents Sales by Country
3.7.2 Middle East and Africa Nasolacrimal Stents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Nasolacrimal Stents Historic Market Analysis by Type
4.1 Global Nasolacrimal Stents Sales Market Share by Type (2016-2021)
4.2 Global Nasolacrimal Stents Revenue Market Share by Type (2016-2021)
4.3 Global Nasolacrimal Stents Price by Type (2016-2021)

5 Global Nasolacrimal Stents Historic Market Analysis by Application
5.1 Global Nasolacrimal Stents Sales Market Share by Application (2016-2021)
5.2 Global Nasolacrimal Stents Revenue Market Share by Application (2016-2021)
5.3 Global Nasolacrimal Stents Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Beaver-Visitec International
6.1.1 Beaver-Visitec International Corporation Information
6.1.2 Beaver-Visitec International Description and Business Overview
6.1.3 Beaver-Visitec International Nasolacrimal Stents Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Beaver-Visitec International Product Portfolio
6.1.5 Beaver-Visitec International Recent Developments/Updates
6.2 Kaneka
6.2.1 Kaneka Corporation Information
6.2.2 Kaneka Description and Business Overview
6.2.3 Kaneka Nasolacrimal Stents Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Kaneka Product Portfolio
6.2.5 Kaneka Recent Developments/Updates
6.3 Bess Medizintechnik GmbH
6.3.1 Bess Medizintechnik GmbH Corporation Information
6.3.2 Bess Medizintechnik GmbH Description and Business Overview
6.3.3 Bess Medizintechnik GmbH Nasolacrimal Stents Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bess Medizintechnik GmbH Product Portfolio
6.3.5 Bess Medizintechnik GmbH Recent Developments/Updates
6.4 FCI Ophthalmics
6.4.1 FCI Ophthalmics Corporation Information
6.4.2 FCI Ophthalmics Description and Business Overview
6.4.3 FCI Ophthalmics Nasolacrimal Stents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 FCI Ophthalmics Product Portfolio
6.4.5 FCI Ophthalmics Recent Developments/Updates
6.5 Fruida
6.5.1 Fruida Corporation Information
6.5.2 Fruida Description and Business Overview
6.5.3 Fruida Nasolacrimal Stents Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Fruida Product Portfolio
6.5.5 Fruida Recent Developments/Updates
6.6 Sinopsys Surgical
6.6.1 Sinopsys Surgical Corporation Information
6.6.2 Sinopsys Surgical Description and Business Overview
6.6.3 Sinopsys Surgical Nasolacrimal Stents Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sinopsys Surgical Product Portfolio
6.6.5 Sinopsys Surgical Recent Developments/Updates

7 Nasolacrimal Stents Manufacturing Cost Analysis
7.1 Nasolacrimal Stents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nasolacrimal Stents
7.4 Nasolacrimal Stents Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nasolacrimal Stents Distributors List
8.3 Nasolacrimal Stents Customers

9 Nasolacrimal Stents Market Dynamics
9.1 Nasolacrimal Stents Industry Trends
9.2 Nasolacrimal Stents Growth Drivers
9.3 Nasolacrimal Stents Market Challenges
9.4 Nasolacrimal Stents Market Restraints

10 Global Market Forecast
10.1 Nasolacrimal Stents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nasolacrimal Stents by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nasolacrimal Stents by Type (2022-2027)
10.2 Nasolacrimal Stents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nasolacrimal Stents by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nasolacrimal Stents by Application (2022-2027)
10.3 Nasolacrimal Stents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nasolacrimal Stents by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nasolacrimal Stents by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nasolacrimal Stents Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nasolacrimal Stents Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Nasolacrimal Stents Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nasolacrimal Stents Covered in This Study
Table 5. Global Nasolacrimal Stents Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Nasolacrimal Stents Sales Share by Manufacturers (2016-2021)
Table 7. Global Nasolacrimal Stents Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nasolacrimal Stents Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nasolacrimal Stents Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nasolacrimal Stents Manufacturing Sites and Area Served
Table 11. Manufacturers Nasolacrimal Stents Product Type
Table 12. Global Nasolacrimal Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nasolacrimal Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasolacrimal Stents as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nasolacrimal Stents Sales by Region (2016-2021) & (K Units)
Table 16. Global Nasolacrimal Stents Sales Market Share by Region (2016-2021)
Table 17. Global Nasolacrimal Stents Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nasolacrimal Stents Sales by Country (2016-2021) & (K Units)
Table 19. North America Nasolacrimal Stents Sales Market Share by Country (2016-2021)
Table 20. North America Nasolacrimal Stents Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nasolacrimal Stents Revenue Market Share by Country (2016-2021)
Table 22. Europe Nasolacrimal Stents Sales by Country (2016-2021) & (K Units)
Table 23. Europe Nasolacrimal Stents Sales Market Share by Country (2016-2021)
Table 24. Europe Nasolacrimal Stents Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nasolacrimal Stents Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nasolacrimal Stents Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Nasolacrimal Stents Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nasolacrimal Stents Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nasolacrimal Stents Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nasolacrimal Stents Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Nasolacrimal Stents Sales Market Share by Country (2016-2021)
Table 32. Latin America Nasolacrimal Stents Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nasolacrimal Stents Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nasolacrimal Stents Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Nasolacrimal Stents Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nasolacrimal Stents Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nasolacrimal Stents Revenue Market Share by Country (2016-2021)
Table 38. Global Nasolacrimal Stents Sales (K Units) by Type (2016-2021)
Table 39. Global Nasolacrimal Stents Sales Market Share by Type (2016-2021)
Table 40. Global Nasolacrimal Stents Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nasolacrimal Stents Revenue Share by Type (2016-2021)
Table 42. Global Nasolacrimal Stents Price (US$/Unit) by Type (2016-2021)
Table 43. Global Nasolacrimal Stents Sales (K Units) by Application (2016-2021)
Table 44. Global Nasolacrimal Stents Sales Market Share by Application (2016-2021)
Table 45. Global Nasolacrimal Stents Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nasolacrimal Stents Revenue Share by Application (2016-2021)
Table 47. Global Nasolacrimal Stents Price (US$/Unit) by Application (2016-2021)
Table 48. Beaver-Visitec International Corporation Information
Table 49. Beaver-Visitec International Description and Business Overview
Table 50. Beaver-Visitec International Nasolacrimal Stents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Beaver-Visitec International Nasolacrimal Stents Product
Table 52. Beaver-Visitec International Recent Developments/Updates
Table 53. Kaneka Corporation Information
Table 54. Kaneka Description and Business Overview
Table 55. Kaneka Nasolacrimal Stents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Kaneka Nasolacrimal Stents Product
Table 57. Kaneka Recent Developments/Updates
Table 58. Bess Medizintechnik GmbH Corporation Information
Table 59. Bess Medizintechnik GmbH Description and Business Overview
Table 60. Bess Medizintechnik GmbH Nasolacrimal Stents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Bess Medizintechnik GmbH Nasolacrimal Stents Product
Table 62. Bess Medizintechnik GmbH Recent Developments/Updates
Table 63. FCI Ophthalmics Corporation Information
Table 64. FCI Ophthalmics Description and Business Overview
Table 65. FCI Ophthalmics Nasolacrimal Stents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. FCI Ophthalmics Nasolacrimal Stents Product
Table 67. FCI Ophthalmics Recent Developments/Updates
Table 68. Fruida Corporation Information
Table 69. Fruida Description and Business Overview
Table 70. Fruida Nasolacrimal Stents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Fruida Nasolacrimal Stents Product
Table 72. Fruida Recent Developments/Updates
Table 73. Sinopsys Surgical Corporation Information
Table 74. Sinopsys Surgical Description and Business Overview
Table 75. Sinopsys Surgical Nasolacrimal Stents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Sinopsys Surgical Nasolacrimal Stents Product
Table 77. Sinopsys Surgical Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Nasolacrimal Stents Distributors List
Table 81. Nasolacrimal Stents Customers List
Table 82. Nasolacrimal Stents Market Trends
Table 83. Nasolacrimal Stents Growth Drivers
Table 84. Nasolacrimal Stents Market Restraints
Table 85. Global Nasolacrimal Stents Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Nasolacrimal Stents Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Nasolacrimal Stents Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Nasolacrimal Stents Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Nasolacrimal Stents Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Nasolacrimal Stents Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Nasolacrimal Stents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Nasolacrimal Stents Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Nasolacrimal Stents Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Nasolacrimal Stents Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Nasolacrimal Stents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Nasolacrimal Stents Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nasolacrimal Stents
Figure 2. Global Nasolacrimal Stents Market Share by Type in 2020 & 2027
Figure 3. Monocanalicular Stents Product Picture
Figure 4. Bicanalicular Stents Product Picture
Figure 5. Global Nasolacrimal Stents Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Global Nasolacrimal Stents Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Nasolacrimal Stents Market Size 2016-2027 (US$ Million)
Figure 11. Global Nasolacrimal Stents Sales 2016-2027 (K Units)
Figure 12. Global Nasolacrimal Stents Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Nasolacrimal Stents Sales Share by Manufacturers in 2020
Figure 14. Global Nasolacrimal Stents Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Nasolacrimal Stents Players: Market Share by Revenue in 2020
Figure 16. Nasolacrimal Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Nasolacrimal Stents Sales Market Share by Region (2016-2021)
Figure 18. Global Nasolacrimal Stents Sales Market Share by Region in 2020
Figure 19. Global Nasolacrimal Stents Revenue Market Share by Region (2016-2021)
Figure 20. Global Nasolacrimal Stents Revenue Market Share by Region in 2020
Figure 21. U.S. Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Nasolacrimal Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Nasolacrimal Stents by Type (2016-2021)
Figure 46. Sales Market Share of Nasolacrimal Stents by Application (2016-2021)
Figure 47. Sales Market Share of Nasolacrimal Stents by Application in 2020
Figure 48. Revenue Share of Nasolacrimal Stents by Application (2016-2021)
Figure 49. Revenue Share of Nasolacrimal Stents by Application in 2020
Figure 50. Manufacturing Cost Structure of Nasolacrimal Stents
Figure 51. Manufacturing Process Analysis of Nasolacrimal Stents
Figure 52. Nasolacrimal Stents Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed